3Lechleitner M, Koch T, Herold M, et al. Tumor necrosis factor alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and card-iovascular risk factors[J] .J Intern Med,2000,248:67-76.
4John C P, Gary D C, Stephen M T, et al. Plasma interleu-kin 6, tumor necrosis factor α and blood cytokine production in type 2 diabetes[J]. Life Sci,2000,67:291-300.
5Pfeiffer A, Janott J, Mohlig M, et al. Circulating tumor ne-crosis factor α is elevated in male but not in female patients with type Ⅱ diabetes mellitus [ J]. Horm Metab Res, 1997,29:111-114.
6Hellmich B, Schellner M, Schatz H, et al. Activation of transforming growth factor β in diabetic kidney disease[J].Metabolism, 2000,49: 355-359.
7Alessandro A, Paola C, Stefania M, et al. Nonenzymatically glycated albumin(Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells[J]. Kidney Int, 1997,51:27-35.
8Sugimoto H, Shikata K, Wada J, et al. Advanced glycation endproducts-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the over expression of tumour necrosis factor α and inducible nitric oxide synthase in diabetic rat glomeruli[J].Diabetologia, 1999,42: 878-886.
9Ohmori M, Harada K, Kitoh Y, et al. The functions of circulatory polymorphonuclear leukocytes in diabetic patients with and without diabetic triopathy [J]. Life Sci, 2000,66:1861-1870.
10Fournier T, Fadok V, Henson P, et al. Tumor necrosis factor alpha inversely regulates prostaglandin D2 and pros-taglandin E2 production in murine nacrophages, synergistic action of cyclic AMP on cyclooxygenase 2 expression and prostaglandin E2 synthesis[J]. J Biol Chem, 1997,272: 31-65.
